Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Secretome Therapeutics Appoints Dr. Teji Singh As Chief Medical Officer

PRIVATEJul 27, 2026•13 days ago

Position

Chief Medical Officer

Company

Secretome Therapeutics

Dr. Teji Singh
BaltimoreBiotechnology

Description

Secretome Therapeutics has expanded its leadership team with new appointments. Dr. Teji Singh is appointed as Chief Medical Officer, enhancing their focus on rare disease therapies.

Company Information

Company

Secretome Therapeutics

Location

323 W Camden St, Suite 600

Baltimore, Maryland, United States

About

Secretome Therapeutics is developing a platform of first-in-class therapeutics derived from neonatal mesenchymal stem cells (nMSC) for the treatment and prevention of underserved diseases. Our lead product, STM-21, is a novel secretome in development for adult and pediatric forms of heart failure, and our pipeline includes novel secretomes in development for neurodegenerative and dermatological diseases.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Secretome Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.